Skip to main content
TipRanks
Go Ultimate75% OFF

BioNTech SE (22UA) Stock Forecast & Price Target

63 Followers
See the Price Targets and Ratings of:

22UA Analyst Ratings

Strong Buy
16Ratings
12Buy4Hold0Sell
Based on 16 analysts giving stock ratings to BioNTech SE in the past 3 months

22UA Stock 12 Month Forecast

€109.97▲(39.91% Upside)
Based on 16 Wall Street analysts offering 12 month price targets for BioNTech SE in the last 3 months. The average price target is EUR 109.97 with a high forecast of EUR 127.02 and a low forecast of EUR 86.19. The average price target represents a 39.91% change from the last price of EUR 78.60.
Highest Price Target€127.02Average Price Target€109.97Lowest Price Target€86.19

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:22UA
Price TargetArticle
Bank of America Securities€97.98buy24.66%UpsideReiterated11/16/26
Citi€113.41buy44.28%UpsideReiterated11/11/26
H.C. Wainwright€117.94→€99.80buy26.97%UpsideReiterated11/10/26
Morgan Stanley€96.17buy22.35%UpsideAssigned11/09/26
Bernstein€87.10hold10.81%UpsideReiterated11/06/26
Jefferies€125.20buy59.29%UpsideReiterated11/04/26
Canaccord Genuity€119.76buy52.36%UpsideReiterated11/04/26
UBS€122.48→€113.41buy44.28%UpsideReiterated11/04/26
Wells Fargo€127.02→€113.41buy44.28%UpsideReiterated11/04/26
Goldman Sachs€115.22buy46.59%UpsideReiterated11/04/26
BMO Capital€95.26→€86.19hold9.65%UpsideAssigned11/03/26
J.P. Morgan―hold―Reiterated10/27/26
Evercore ISI€117.94buy50.05%UpsideReiterated10/13/26
Berenberg Bank€127.02buy61.60%UpsideReiterated10/07/26
Argus Research―hold―Initiated10/07/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PLSEPulse Biosciences
SLDBSolid Biosciences
RZLTRezolute
IMUXImmunic
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering BioNTech SE

3 Months
Akash Tewari
Akash TewariJefferies
Success Rate9/16 ratings generated profit
56%
Average Return
+3.02%

Copying Akash Tewari's trades and holding each position for 3 Months would result in 56.25% of your transactions generating a profit, with an average return of +3.02% per trade.

1 Year
Robert Burns
Robert BurnsH.C. Wainwright
Success Rate9/22 ratings generated profit
41%
Average Return
+0.10%

Copying Robert Burns's trades and holding each position for 1 Year would result in 40.91% of your transactions generating a profit, with an average return of +0.10% per trade.

2 Years
Robert Burns
Robert BurnsH.C. Wainwright
Success Rate7/22 ratings generated profit
32%
Average Return
-5.80%

Copying Robert Burns's trades and holding each position for 2 Years would result in 31.82% of your transactions generating a profit, with an average return of -5.80% per trade.

22UA Analyst Recommendation Trends

020406080Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 22UA
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy86453
Buy1021334840
Hold55698
Sell00000
Strong Sell00000
total2332436251

In the current month, 22UA has received 43 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. 22UA average Analyst price target in the past 3 months is 109.97.

22UA Financial Forecast

€-5€-3.5€-2€-0.5€1Q1 2026Q3 2026Q4 2026
High€-1.02
Consensus€-1.71
Low€-3.16

22UA Earnings Forecast

Next quarter’s earnings estimate for 22UA is -EUR 1.71 with a range of -EUR 3.16 to -EUR 1.02. The previous quarter’s EPS was EUR 0.73. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€110.6M€417.2M€723.7M€1B€1.3BQ1 2026Q3 2026Q4 2026
High€600M
Consensus€386M
Low€278M

22UA Sales Forecast

Next quarter’s sales forecast for 22UA is EUR 385.63M with a range of EUR 278.48M to EUR 599.71M. The previous quarter’s sales results were EUR 1.34B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

22UA Stock Forecast FAQ

What is DE:22UA’s average 12-month price target, according to analysts?
Based on analyst ratings, BioNTech SE’s 12-month average price target is €109.97.
What is DE:22UA’s upside potential, based on the analysts’ average price target?
BioNTech SE has 39.91% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BioNTech SE a Buy, Sell or Hold?
BioNTech SE has a consensus rating of Strong Buy, which is based on 12 buy ratings, 4 hold ratings and 0 sell ratings.
What is BioNTech SE’s share price target?
The average share price target for BioNTech SE is €109.97. This is based on 16 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €127.02, and the lowest forecast is €86.19. The average share price target represents a 39.91% increase from the current price of €78.6.
What do analysts say about BioNTech SE?
BioNTech SE’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Street analysts.
How can I buy shares of BioNTech SE?
To buy shares of DE:22UA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.